ADAM8 and neoplasm: Using commercially available reagent-grade anti-ADAM8 Abs, we showed proof-of-concept that dual MP and DI inhibitory Abs can be isolated, and using one such inhibitor demonstrated efficacy against both primary tumor growth and metastasis; the mechanism driving dual inhibition was not elucidated [6].